Release
📈 Stocks
Abbisko Therapeutics and Merck KGaA Secure U.S. FDA Approval for PIMJETMI
(just now)
Abbisko Therapeutics and Merck KGaA received U.S. FDA approval for PIMJETMI to treat symptomatic TGCT, triggering a milestone payment and marking the…